Mayne Pharma Ventures Pty Ltd - Net Worth and Insider Trading
Mayne Pharma Ventures Pty Ltd Net Worth
The estimated net worth of Mayne Pharma Ventures Pty Ltd is at least $17 Million dollars as of 2024-11-13. Mayne Pharma Ventures Pty Ltd is the 10% Owner of Inhibitor Therapeutics Inc and owns about 198,106,132 shares of Inhibitor Therapeutics Inc (INTI) stock worth over $17 Million. Details can be seen in Mayne Pharma Ventures Pty Ltd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mayne Pharma Ventures Pty Ltd has not made any transactions after 2017-12-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mayne Pharma Ventures Pty Ltd
Mayne Pharma Ventures Pty Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mayne Pharma Ventures Pty Ltd owns 1 companies in total, including Inhibitor Therapeutics Inc (INTI) .
Click here to see the complete history of Mayne Pharma Ventures Pty Ltd’s form 4 insider trades.
Insider Ownership Summary of Mayne Pharma Ventures Pty Ltd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INTI | Inhibitor Therapeutics Inc | 2020-07-15 | 10 percent owner |
Mayne Pharma Ventures Pty Ltd Latest Holdings Summary
Mayne Pharma Ventures Pty Ltd currently owns a total of 1 stock. Mayne Pharma Ventures Pty Ltd owns 198,106,132 shares of Inhibitor Therapeutics Inc (INTI) as of December 19, 2017, with a value of $17 Million.
Latest Holdings of Mayne Pharma Ventures Pty Ltd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INTI | Inhibitor Therapeutics Inc | 2017-12-19 | 198,106,132 | 0.09 | 16,839,021 |
Holding Weightings of Mayne Pharma Ventures Pty Ltd
Mayne Pharma Ventures Pty Ltd Form 4 Trading Tracker
According to the SEC Form 4 filings, Mayne Pharma Ventures Pty Ltd has made a total of 0 transactions in Inhibitor Therapeutics Inc (INTI) over the past 5 years. The most-recent trade in Inhibitor Therapeutics Inc is the acquisition of 600,000 shares on December 19, 2017, which cost Mayne Pharma Ventures Pty Ltd around $97.6 Billion.
Insider Trading History of Mayne Pharma Ventures Pty Ltd
- 1
Mayne Pharma Ventures Pty Ltd Trading Performance
GuruFocus tracks the stock performance after each of Mayne Pharma Ventures Pty Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mayne Pharma Ventures Pty Ltd is 34.78%. GuruFocus also compares Mayne Pharma Ventures Pty Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mayne Pharma Ventures Pty Ltd within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mayne Pharma Ventures Pty Ltd's insider trading performs compared to the benchmark.
Performance of Mayne Pharma Ventures Pty Ltd
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 30.43 | | | | | |
| Relative Return to S&P 500(%) | 25.63 | | | | | |
Mayne Pharma Ventures Pty Ltd Ownership Network
Ownership Network List of Mayne Pharma Ventures Pty Ltd
Ownership Network Relation of Mayne Pharma Ventures Pty Ltd
Mayne Pharma Ventures Pty Ltd Owned Company Details
What does Inhibitor Therapeutics Inc do?
Who are the key executives at Inhibitor Therapeutics Inc?
Mayne Pharma Ventures Pty Ltd is the 10 percent owner of Inhibitor Therapeutics Inc. Other key executives at Inhibitor Therapeutics Inc include 10 percent owner Ronald E Osman Irrevocable Trust Iii , director & 10 percent owner Ronald E Osman , and 10 percent owner Tpb 2012 Llc .
Inhibitor Therapeutics Inc (INTI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Inhibitor Therapeutics Inc (INTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inhibitor Therapeutics Inc (INTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Inhibitor Therapeutics Inc (INTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibitor Therapeutics Inc Insider Transactions
Mayne Pharma Ventures Pty Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Mayne Pharma Ventures Pty Ltd. You might contact Mayne Pharma Ventures Pty Ltd via mailing address: 1538 Main North Road, Salisbury South, Sa C3 5106.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
